Inducible expression of p21(WAF-1/CIP-1/SDI-1) from a promoter conversion retroviral vector

Journal of Molecular Medicine

Volumn 75, Issue 11-12, 1997, Pages 820-828

  Mrochen, Stefan ^a,b,f   Klein, Dieter ^a,c   Nikol, Sigrid ^b   Smith, James R ^d   Salmons, Brian ^c   Günzburg, Walter H ^a,e  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Bavarian Nordic GmbH   (Germany)

^d Division of Molecular Virology   (United States)

^e UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell cycle control; Conditional expression; Mouse mammary tumor virus long terminal repeat; Retroviral vector; WAF 1 CIP 1 SDI 1

Indexed keywords

VIRUS VECTOR; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DEXAMETHASONE;

ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; KIDNEY CELL; LONG TERMINAL REPEAT; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ANIMAL; BIOSYNTHESIS; CAT; CELL CULTURE; CELL DIVISION; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; METABOLISM; MOUSE; MURINE LEUKEMIA VIRUS; PROMOTER REGION; SYNTHESIS;

ANIMALS; CATS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEXAMETHASONE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; MAMMARY TUMOR VIRUS, MOUSE; MICE; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0030608672     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050171     Document Type: Article

References (24)

1. Noda A, Ning Y, Venable SF, Periera-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
3. El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potent mediator of p53 tumor suppression. Cell 75:817-825
4. Jiang H, Lin J, Su ZZ, Collart FR Huberman E, Fisher PB (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF/CIP1 expression in the absence of p53. Oncogene 9:3397-3406
5. Nakanishi M, Adami GR, Robetorye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith O, Smith JR (1995) Exit from Go and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci USA 92:4352-4356
6. Gunzburg WH, Salmons B (1992) Factors controlling the expression of mouse mammary tumor virus. Biochem J 283:625-632
7. Price J, Turner D, Cepko C (1987) Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 84: 156-160
8. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990
9. Parada LF, Tabin CJ, Shih C, Weinberg RA (1982) Human EJ bladder carcinoma oncogene is the homologue of Harvey sarcoma virus ras gene. Nature 297:474-478
10. Crandell RA, Fabricant CG, Nelson-Rees WA (1973) Development, characterization, and virus susceptibility of a feline (Felis catus) renal cell line (CRFK). In vitro 9:176-185
11. Miller AD, Buttimore C (1989) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902
12. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033-8037
13. Günzburg WH, Salmons B (1986) Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 155:236-248
14. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
15. Nusse M, Beisker W, Kramer J, Miller BM, Schreiber GA, Viaggi S, Weller EM, Wessels JM (1994) Measurment of micronuclei by flow cytometry. Methods Cell Biol 42:149
16. Salmons B, Sailer RM, Baumann JG, Gunzburg WH (1995) Construction of retroviral vectors for targeted delivery and expression of therapeutic genes. Leukemia 9 [Suppl 1]:53-60
17. Jaggi R, Salmons B, Muellener D, Groner B (1986) The v-mos and H-ras oncogene expression represses glucocorticoid hormone dependent transcription from the mouse mammary tumor virus LTR. EMBO J 6:2609-2616
18. Sparmann G, Walther W, Gunzburg WH, Uckert W, Salmons B (1994) Conditional expression of human TNF-α: a system for inducible cytotoxicity. Int J Cancer 59:103-107
19. Nikol S, Huehns TY, Höfling B (1996) Molecular biology and post-angioplasty resentosis. Atherosclerosis 123:17-31
20. Gunzburg WH, Salmons B (1996) Development of retroviral vectors as safe, targeted gene delivery systems. J Mol Med 74:171-182
21. Overhauser J, Fan H (1985) Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat. J Virol 54:133-144
22. Yang Z-Y, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG (1996) Role of the p21 cyclin-dependent kinase inhibitor in limiting intimai cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 93:7905-7910
23. Yang Z-Y, Perkins ND, Ohno T, Nabel EG, Nabel GJ (1995) The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1:1052-1056
24. Gunzburg WH, Salmons B (1995) Virus vector design in gene therapy. Mol Med Today 1:410-417